Neuroleptic malignant syndrome in a patient with acquired immunodeficiency syndrome

W. B. Bernstein*, B. Scherokman

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Abstract

ABSTRACT A patient with acquired immunodeficiency syndrome treated with prochlor‐perazine and droperidol developed neuroleptic malignant syndrome, characterized by akinetic mutism, resting tremor, cogwheel rigidity, and elevated serum creatine phosphokinase. An identical syndrome reappeared with subsequent administration of haloperidol. Neuroleptic malignant syndrome has not been previously reported in acquired immunodeficiency syndrome. 1986 Blackwell Munksgaard

Original languageEnglish
Pages (from-to)636-637
Number of pages2
JournalActa Neurologica Scandinavica
Volume73
Issue number6
DOIs
StatePublished - Jun 1986
Externally publishedYes

Keywords

  • acquired immunodeficiency syndrome
  • droperidol
  • haloperidol
  • neuroleptic malignant syndrome
  • prochlorperazine

Fingerprint

Dive into the research topics of 'Neuroleptic malignant syndrome in a patient with acquired immunodeficiency syndrome'. Together they form a unique fingerprint.

Cite this